Image

Comparison of the Efficacy of Intravenous Fluid Administration Between Bolus and Continuous Infusion in Pregnant Women With Fetal Heart Rate Tracing Category II: A Randomized Controlled Trial

Comparison of the Efficacy of Intravenous Fluid Administration Between Bolus and Continuous Infusion in Pregnant Women With Fetal Heart Rate Tracing Category II: A Randomized Controlled Trial

Recruiting
20-35 years
Female
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to compare the efficacy of two methods of intravenous (IV) fluid administration-bolus infusion versus continuous infusion-for intrauterine resuscitation in pregnant women who present with Category II fetal heart rate (FHR) tracings during labor. The main research question is:

Does intrauterine resuscitation using an adjusted IV hydration bolus of normal saline more effectively convert the FHR tracing from Category II to Category I within 30 minutes compared to adjusted IV hydration using a continuous infusion of 1000 mL normal saline at 150 mL/hour? Objectives

Primary Objective:

\- To compare the rate of improvement of electronic fetal monitoring (EFM) category from Category II to Category I within 30 minutes between two hydration methods: Normal saline bolus loading (adjusted dose) Normal saline continuous infusion (1000 mL at 150 mL/hr)

Secondary Objectives:

  • To identify the characteristics of IV fluid administration used during intrauterine resuscitation.
  • To determine whether fluid bolus improves fetal heart rate patterns more rapidly or effectively than continuous infusion.

Methods

Study Design: Randomized controlled trial with block randomization (block of four).

Participants: Pregnant women in labor who present with Category II FHR tracing on admission.

Intervention

Group A: Adjusted IV hydration with normal saline bolus loading. Group B: Adjusted IV hydration with normal saline continuous infusion (1000 mL at 150 mL/hr).

Monitoring: Electronic fetal monitoring (EFM) will be continuously observed to detect any change in FHR category after intervention.

Primary Outcome: Conversion of FHR from Category II to Category I within 30 minutes.

Description

This is a randomized controlled trial study to compare the efficacy of two methods of intravenous (IV) fluid administration-bolus infusion versus continuous infusion-for intrauterine resuscitation in pregnant women who present with Category II fetal heart rate (FHR) tracings during labor

There are 2 interventions :

Intervention 1 (Bolus Group):

Participants receive 500 mL of normal saline (NSS) intravenously as a bolus over 20 minutes, followed by 1,000 mL of NSS infused continuously at 150 mL/hour.

Intervention 2 (Continuous Infusion Group):

Participants receive 1,000 mL of normal saline infused continuously at 150 mL/hour without a preceding bolus.

Short-term Outcome Collection

Primary short-term outcome:

Conversion of FHR Category II to Category I within 30 minutes after starting the assigned IV hydration regimen, assessed by continuous electronic fetal monitoring (EFM).

Secondary short-term outcomes:

Measured at baseline, 10 minutes, and 30 minutes after intervention:

Maternal hemodynamic parameters: Blood pressure, heart rate, respiratory rate, SpO₂ IVC collapsibility index (IVC-CI) assessed by ultrasound (M-mode) Umbilical artery Doppler indices: Resistance Index (RI), Pulsatility Index (PI), S/D ratio FHR variability and deceleration pattern All outcomes are recorded in the Case Record Form (CRF) by blinded assessors. All participants are women in labor with Category II fetal heart rate (FHR) tracing, randomized by block randomization (block size = 4).

During the intervention, standard intrauterine resuscitation measures (maternal left lateral position, discontinuation of oxytocin, oxygen 15 L/min by mask if indicated) are maintained uniformly.

Eligibility

Inclusion Criteria:

  1. Singleton
  2. Thai nationality
  3. Gestational Age more than equal 37 Weeks
  4. Maternal Age 20-35 Years
  5. Cephalic Presentation
  6. Electronic Fetal Monitoring (EFM) Category II

Exclusion Criteria:

  1. Maternal underlying diseases : Cardiac disease, Pulmonary disease), Overt DM, Thyroid disease,. etc
  2. High risk pregnancy :Pre-eclampsia/Eclampsia), GDM
  3. Fetal abnormalities
  4. Maternal receiving medications for example : Magnesium sulfate, Pethidine, Opioids
  5. Oligohydramnios

Study details
    Fetal Non Reassuring

NCT07260240

Queen Savang Vadhana Memorial Hospital, Thailand

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.